News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Heffernan Michael Thomas
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/30/2023 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $2.27, valued at
$68.1k
|
|
| 05/19/2023 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Granted 9,792 shares
@ $0 |
|
| 05/04/2023 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on Biohaven Ltd.|
Txns:
| Granted 52,906 options to buy
@ $13.2, valued at
$698.4k
|
|
| 12/27/2022 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Sold 237 shares
@ $23, valued at
$5.5k
Sold 4,989 shares
@ $23, valued at
$114.7k
Sold 15,995 shares
@ $23.63, valued at
$378k
Sold 3,820 shares
@ $24.16, valued at
$92.3k
Exercised 237 options to buy
@ $16.15, valued at
$3.8k
Exercised 4,989 options to buy
@ $16.15, valued at
$80.6k
Exercised 15,995 options to buy
@ $16.15, valued at
$258.3k
Exercised 3,820 options to buy
@ $16.15, valued at
$61.7k
|
|
| 12/21/2022 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Sold 3,606 shares
@ $23.04, valued at
$83.1k
Sold 33,758 shares
@ $23.08, valued at
$779.1k
Sold 46,600 shares
@ $23.11, valued at
$1.1M
Exercised 3,606 options to buy
@ $16.15, valued at
$58.2k
Exercised 33,758 options to buy
@ $16.15, valued at
$545.2k
Exercised 46,600 options to buy
@ $16.15, valued at
$752.6k
|
|
| 12/14/2022 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Sold 27,920 shares
@ $22.01, valued at
$614.5k
Sold 161,687 shares
@ $22.16, valued at
$3.6M
Exercised 10,669 options to buy
@ $14.9, valued at
$159k
Exercised 15,741 options to buy
@ $15.27, valued at
$240.4k
Exercised 1,510 options to buy
@ $14.57, valued at
$22k
Exercised 59,524 options to buy
@ $14.9, valued at
$886.9k
Exercised 94,259 options to buy
@ $15.27, valued at
$1.4M
Exercised 7,904 options to buy
@ $14.57, valued at
$115.2k
|
|
| 10/12/2022 |
4/A
| Heffernan Michael Thomas (Director) has filed a Form 4 on Biohaven Ltd.|
Txns:
| Paid exercise price by delivering 9,699 shares
@ $7.5, valued at
$72.7k
|
|
| 10/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/01/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on SYNLOGIC, INC.|
Txns:
| Granted 27,000 options to buy
@ $1.17, valued at
$31.6k
|
|
| 05/23/2022 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Granted 14,035 shares
@ $0 |
|
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2021 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Granted 3,320 options to buy
@ $0 |
|
| 06/17/2021 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.25, valued at
$45k
|
|
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Granted 9,941 shares
@ $0 |
|
| 05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/26/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 03/17/2021 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Sold 47,044 shares
@ $25.26, valued at
$1.2M
Sold 3,031 shares
@ $25.88, valued at
$78.4k
|
|
| 12/09/2020 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on SYNLOGIC, INC.|
Txns:
| Granted 30,000 options to buy
@ $2.29, valued at
$68.7k
|
|
| 12/09/2020 |
3
| Heffernan Michael Thomas (Director) has filed a Form 3 on SYNLOGIC, INC. |
| 08/12/2020 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Sold 13,071 shares
@ $19.13, valued at
$250k
|
|
| 06/15/2020 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 14,210 options to buy
@ $4.1, valued at
$58.3k
|
|
| 06/09/2020 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 13,700 shares
@ $0
Granted 20,100 options to buy
@ $11.96, valued at
$240.4k
|
|
| 05/22/2020 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Paid exercise price by delivering 18,650 shares
@ $22.05, valued at
$411.2k
Granted 4,047 shares
@ $0
Granted 8,095 options to buy
@ $22.05, valued at
$178.5k
|
|
| 05/15/2020 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Sold 1,380 shares
@ $20.92, valued at
$28.9k
Sold 11,969 shares
@ $21.21, valued at
$253.9k
Sold 5,905 shares
@ $22.64, valued at
$133.7k
|
|
| 05/01/2020 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Granted 18,000 options to buy
@ $47.1, valued at
$847.8k
|
|
| 02/12/2020 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Paid exercise price by delivering 4,962 shares
@ $21.62, valued at
$107.3k
|
|
| 01/31/2020 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Granted 36,000 options to buy
@ $48.49, valued at
$1.7M
|
|
| 01/31/2020 |
3
| Heffernan Michael Thomas (Director) has filed a Form 3 on Biohaven Pharmaceutical Holding Co Ltd. |
|
|
|